48 out of 51 reporting countries saw PEPFAR-supported HIV testing drop after the funding freeze and stop-work orders by an average of 30%. As of 2026, testing levels have largely rebounded.
Date: 2/26
Region: Global
Country: Global
Topic: Health
Policy Lens: Global Health Security
Entry Type: System Impact
Additional Context: In February 2026, the U.S. government released partial annual data for the U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR. The Center for Global Development analyzed the data as available at the time but cautioned that the dataset likely contains reporting errors and underreporting. Because the analysis relies on aggregated indicators, it may also miss important shifts in how services were delivered on the ground over the past year.
According to CGD's analysis, 4 million fewer people got tested and received their results under PEPFAR programs between January and March 2025 than in the last months of 2024. About 2.8 million of that decline is accounted for by Zambia, Uganda, Tanzania, Nigeria, and South Africa.
Devex Researcher Note: Though funding was initially frozen in early 2025, many of the "lifesaving" PEPFAR programs rebounded globally while other non-medical but vital support services ended for good. The confusion and disruptions of the initial funding freeze have led to mistrust, misinformation, and harmful coping strategies. Without the auxiliary programs that once were prevalent, reaching those most marginalized will continue to be difficult.
Source: CGD

